| 產(chǎn)品編號(hào) | 圖片 | CAS No. | 名稱及描述 | 規(guī)格 | 價(jià)格 | 分子式 | 快速訂購(gòu) |
|---|---|---|---|---|---|---|---|
| 134900-1G |
|
1372719-95-3 |
(R)-6,6'-雙(2,4,6-三異丙基苯基)螺環(huán)二酚磷酸酯 (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C47H59O4P | |
| 134900-100MG |
|
1372719-95-3 |
(R)-6,6'-雙(2,4,6-三異丙基苯基)螺環(huán)二酚磷酸酯 (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C47H59O4P | |
| 134900-25MG |
|
1372719-95-3 |
(R)-6,6'-雙(2,4,6-三異丙基苯基)螺環(huán)二酚磷酸酯 (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價(jià) | C47H59O4P | |
| 134907-1G |
|
NA |
(S)-6,6'-二(2-萘基)螺環(huán)二酚磷酸酯 (11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C37H27O4P | |
| 134907-100MG |
|
NA |
(S)-6,6'-二(2-萘基)螺環(huán)二酚磷酸酯 (11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C37H27O4P | |
| 134907-25MG |
|
NA |
(S)-6,6'-二(2-萘基)螺環(huán)二酚磷酸酯 (11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價(jià) | C37H27O4P | |
| 134906-1G |
|
1297613-74-1 |
(R)-6,6'-二(2-萘基)螺環(huán)二酚磷酸酯 (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C37H27O4P | |
| 134906-100MG |
|
1297613-74-1 |
(R)-6,6'-二(2-萘基)螺環(huán)二酚磷酸酯 (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C37H27O4P | |
| 134906-25MG |
|
1297613-74-1 |
(R)-6,6'-二(2-萘基)螺環(huán)二酚磷酸酯 (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價(jià) | C37H27O4P | |
| 134849-1G |
|
1258327-08-0 |
(S)-6,6'-二(1-萘基)螺環(huán)二酚磷酸酯 (11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C37H27O4P | |
| 134849-100MG |
|
1258327-08-0 |
(S)-6,6'-二(1-萘基)螺環(huán)二酚磷酸酯 (11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C37H27O4P | |
| 134849-25MG |
|
1258327-08-0 |
(S)-6,6'-二(1-萘基)螺環(huán)二酚磷酸酯 (11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價(jià) | C37H27O4P | |
| 134850-1G |
|
1297613-73-0 |
(R)-6,6'-二(1-萘基)螺環(huán)二酚磷酸酯 (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C37H27O4P | |
| 134850-100MG |
|
1297613-73-0 |
(R)-6,6'-二(1-萘基)螺環(huán)二酚磷酸酯 (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C37H27O4P | |
| 134850-25MG |
|
1297613-73-0 |
(R)-6,6'-二(1-萘基)螺環(huán)二酚磷酸酯 (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價(jià) | C37H27O4P | |
| 134899-1G |
|
1412439-82-7 |
(S)-6,6'-雙(3,5-二甲基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(3,5-dimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,98%e.e. |
1G | 需詢價(jià) | C33H31O4P | |
| 134899-100MG |
|
1412439-82-7 |
(S)-6,6'-雙(3,5-二甲基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(3,5-dimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,98%e.e. |
100MG | 需詢價(jià) | C33H31O4P | |
| 134899-25MG |
|
1412439-82-7 |
(S)-6,6'-雙(3,5-二甲基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(3,5-dimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,98%e.e. |
25MG | 需詢價(jià) | C33H31O4P | |
| 134898-1G |
|
1297613-75-2 |
(R)-6,6'-雙(3,5-二甲基苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(3,5-dimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C33H31O4P | |
| 134898-100MG |
|
1297613-75-2 |
(R)-6,6'-雙(3,5-二甲基苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(3,5-dimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C33H31O4P | |
小泰
|
010-60710855
|